Marathons safe even for older runners–but there are limitsCardiac changes appear to be transient, though ultra-endurance events may be the ‘edge of harmful’ Large-scale health study launched in OntarioAll adults in the province asked to volunteer to enroll Uloric: first new option for gout in more than 40 years Takeda Canada will soon be introducing Uloric (febuxostat 80 mg) tablets, the first new drug to be marketed for gout in more than four decades. Practice Issues: Adverse Reactions - TMP-SMX interaction with ACEIs and ARBs Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers are usually well-tolerated drugs. Men and Women's Health 2010: Menopause Current Management of Menopausal Symptoms. Much ado about magnesium Magnesium is one of those under-appreciated, but very interesting supplements. Drug News: October 2010 Dexilant: new PPI, lansoprazole enantiomer; Prolia: twice-yearly SC injection for osteoporosis; Thalidomide approved for multiple myeloma. Practice Issues: Adverse reactions - Testosterone safety in older men Study addresses safety and efficacy of testosterone treatment in older men who have limitations in mobility. Men and Women's Health 2010: Dyslipidemia Current issues in screening, risk assessment and treatment. RNAO: Shut down of coal-fired power units will save lives Ontario's nurses urges government to close all remaining units this year. First Previous 425 426 427 428 429 Next Last
